相关实验视频

Updated: Jun 8, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

使用虚拟查方法识别新型人类15-氧基酶-2 (h15-LOX-2) 抑制剂

Lucas G Viviani¹, Thais S Iijima¹, Erika Piccirillo²

¹Department of Biochemistry, Institute of Chemistry, University of São Paulo, Av. Prof. Lineu Prestes 748, 05508-000 São Paulo, Brazil.

Journal of medicinal chemistry

|December 19, 2024

概括

研究人员确定了人类15-lipoxygenase-2 (h15-LOX-2) 的新型抑制剂,这种酶与炎症和动脉样硬化有关. 这种虚拟选方法产生了有前途的候选药物,用于进一步开发.

科学领域:

生物化学生物化学
药理学药理学是指药理学的学科.
药用化学医学化学

背景情况:

人类15-氧酶-2 (h15-LOX-2) 在合成炎症性脂质介质中至关重要.
h15-LOX-2在动脉样硬化斑块的形成中发挥作用,使其成为潜在的药物标.

研究的目的:

为了确定人类15-氧酶-2 (h15-LOX-2) 的新型抑制剂.
探索针对炎症和心血管疾病的h15-LOX-2的治疗潜力.

主要方法:

采用了一个虚拟选策略,结合了基于形状的匹配,2D结构不相似性和对接.
应用过器到一个精心策划的ZINC数据库,大约有800万种化合物.
经过实验验证的虚拟查通过生物化学测试得到了成功.

主要成果:

从13种测试化合物中鉴定出6种微分子范围的h15-LOX-2抑制剂 (46.2%的成功率).
对于具有混合类型抑制机制的两种化合物,10和13的确定的抑制常量 (K值).
已识别的抑制剂具有类似药物的特性和新的化学结构.

结论:

虚拟查方法成功地确定了h15-LOX-2的新型药物类抑制剂.
这些化合物代表了开发针对h15-LOX-2相关疾病的新疗法的有希望的线索.
对这些抑制剂的进一步研究可能会在治疗动脉样硬化和炎症疾病方面取得进展.

更多相关视频

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...